⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10130206 | 1.00 | — | — | |
| SCHEMBL10130175 | 1.00 | — | — | |
| SCHEMBL10130223 | 0.86 | GNAI3 (0.46) | — | |
| SCHEMBL12718120 | 0.86 | DRD2 (0.51) | — | |
| SCHEMBL10130235 | 0.86 | GNAI3 (0.46) | — | |
| SCHEMBL17888496 | 0.86 | DRD2 (0.51) | — | |
| SCHEMBL76763 | 0.86 | GNAI3 (0.46) | — | |
| SCHEMBL170825 | 0.86 | DRD2 (0.51) | — | |
| SCHEMBL13907400 | 0.85 | GBA1 (0.41) | — | |
| SCHEMBL1290932 | 0.85 | CARM1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119764547-A | Solid electrolyte based on ionic liquid and preparation method thereof | 浙江蓝德能源科技发展有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260062295-A1 | SALT COMPOSITION FOR LOW-ACETAMIDE-CONTENT ELECTROLYTE | ARKEMA FRANCE (FR) | 2026-03-05 | — | — | US | disclosed |
| US-20260015235-A1 | SALT COMPOSITION FOR AN ELECTROLYTE, HAVING A LOW CONTENT OF SULFAMATE IONS | ARKEMA FRANCE (FR) | 2026-01-15 | — | — | US | disclosed |
| WO-2025128460-A1 | ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF | WILLIAMS RICHARD KENT (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-4558451-A1 | SALT COMPOSITION FOR LOW-ACETAMIDE-CONTENT ELECTROLYTE | ARKEMA FRANCE (FR) | 2025-05-28 | — | — | EP | disclosed |
| EP-4558450-A1 | SALT COMPOSITION FOR AN ELECTROLYTE, HAVING A LOW CONTENT OF SULFAMATE IONS | ARKEMA FRANCE (FR) | 2025-05-28 | — | — | EP | disclosed |
| CN-119764547-A | Solid electrolyte based on ionic liquid and preparation method thereof | 浙江蓝德能源科技发展有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119585198-A | Salt composition for electrolytes with low sulfamate ion content | 阿科玛法国公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024018141-A1 | SALT COMPOSITION FOR AN ELECTROLYTE, HAVING A LOW CONTENT OF SULFAMATE IONS | ARKEMA FRANCE (FR) | 2024-01-25 | — | — | WO | disclosed |
| US-7354946-B2 | prominent growth inhibitory activity against tumor cells; cyclin dependent kinase inhibitors; colon cancer; N'-(3-t-butylisoindolino[3,2-b]oxazolidin-4-on-8-yl)-N-(4-(N-benzylpyrrolidin-3-yl)pyridin-2-yl)urea | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| US-7354946-B2 | prominent growth inhibitory activity against tumor cells; cyclin dependent kinase inhibitors; colon cancer; N'-(3-t-butylisoindolino[3,2-b]oxazolidin-4-on-8-yl)-N-(4-(N-benzylpyrrolidin-3-yl)pyridin-2-yl)urea | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| WO-2008021369-A2 | TRICYCLIC COMPOUNDS AND ITS USE AS TYROSINE KINASE MODULATORS | CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20070167453-A1 | Nitrogenous fused heteroaromatic ring derivative | MSD K.K. (JP) | 2007-07-19 | — | — | US | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| EP-1719756-A1 | NITROGENOUS FUSED HETEROAROMATIC RING DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1717230-A1 | FUSED-RING 4-OXOPYRIMIDINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20050182045-A1 | Fused ring 4-oxopyrimidine derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-0415263-A2 | Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives | Kali-Chemie Aktiengesellschaft (DE) | 1991-03-06 | — | — | EP | disclosed |